вторник, 29 марта 2016 г.

Biogen's Newer Problems; Their Relevance To The Biotech Sector

Biogen's Newer Problems; Their Relevance To The Biotech Sector


Biogen is running into some potentially serious patent issues with its lead drug Tecfidera, which are discussed in some detail herein. The large-cap biotech Biogen has had some major news break.



from Biotech News